Cite
HARVARD Citation
Gutman, D. et al. (2016). A Phase I, Open‐Label, Single‐Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients. Headache. 56 (8), pp. 1300-1309. [Online].